Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

G Protein-coupled Receptors01:15

G Protein-coupled Receptors

G Protein-Coupled Receptors or GPCRs are membrane-bound receptors that transiently associate with heterotrimeric G proteins and induce an appropriate response to sensory stimuli such as light, odors, hormones, cytokines, or neurotransmitters.
GPCRs are also called heptahelical, 7TM, or serpentine receptors, and consist of seven (H1-H7) transmembrane alpha-helices that span the bilayer to form a cylindrical core. The transmembrane helices are connected by three extracellular loops and three...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neutron-Multiplicity Measurement in Muon Capture on Oxygen Nuclei in the Gadolinium-Loaded Super-Kamiokande Detector.

Physical review letters·2026
Same author

X-linked hypophosphatemic rickets: a rare case report.

Acta orthopaedica Belgica·2026
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

Effects of drinking water temperature in summer on growth performance, water consumption, surface temperature, blood parameters, and intestinal development of geese from 14 to 42 days of age.

Poultry science·2026
Same author

Results from the T2K Experiment on Neutrino Mixing Including a New Far Detector μ-like Sample.

Physical review letters·2026
Same author

[Comparison of the efficacy of isoperistaltic and antiperistaltic anastomosis in totally laparoscopic right hemicolectomy: a post-hoc analysis based on a national multicenter snapshot study].

Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery·2025

Related Experiment Video

Updated: Jul 10, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Structure-based design, synthesis, and pharmacologic evaluation of peptide RGS4 inhibitors.

Y Jin1, H Zhong, J R Omnaas

  • 1Department of Medicinal Chemistry, The University of Michigan, Ann Arbor, MI 48109, USA.

The Journal of Peptide Research : Official Journal of the American Peptide Society
|March 11, 2004
PubMed
Summary

Scientists designed cyclic peptides to inhibit Regulators of G-protein signaling (RGS) proteins. These novel compounds target RGS4 GTPase-activating protein (GAP) activity, offering potential therapeutic applications.

More Related Videos

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 27, 2016

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Related Experiment Videos

Last Updated: Jul 10, 2026

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation
08:48

Development of a Backbone Cyclic Peptide Library as Potential Antiparasitic Therapeutics Using Microwave Irradiation

Published on: January 27, 2016

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
10:01

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach

Published on: June 23, 2026

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Pharmacology

Background:

  • Regulators of G-protein signaling (RGS) proteins are crucial modulators of G protein-coupled receptor (GPCR) signaling pathways.
  • RGS proteins function as GTPase-activating proteins (GAPs), accelerating the termination of G protein signaling by promoting GTP hydrolysis on Galpha subunits.

Purpose of the Study:

  • To design and synthesize novel cyclic peptides that inhibit the GTPase-activating protein (GAP) activity of RGS4.
  • To explore the potential of these peptides as tools for studying RGS-mediated signaling and as a basis for new therapeutic agents.

Main Methods:

  • Utilized the known X-ray crystal structure of RGS4 bound to Gialpha1 to guide peptide design.
  • Modeled cyclic peptides based on the Gialpha Switch I region, a key interaction site with RGS proteins.
  • Synthesized and characterized the designed cyclic peptides.

Main Results:

  • Successfully designed and synthesized a series of cyclic peptides targeting the RGS4-Gialpha1 interaction.
  • Demonstrated that these cyclic peptides inhibit the RGS4 GAP activity.
  • These findings validate the peptide design strategy.

Conclusions:

  • The developed cyclic peptides are effective inhibitors of RGS4 GAP activity.
  • These compounds represent valuable pharmacological tools for investigating RGS protein function.
  • The study provides a foundation for developing novel therapeutics targeting RGS-mediated signaling pathways.